Register Financial Advisors LLC Bristol Myers Squibb CO Transaction History

Register Financial Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$40.25 - $52.99 $77,199 - $101,634	-1,918 Reduced 40.06%	2,870 $119 Million
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $229,728 - $260,467	4,788 New	4,788 $260 Million
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $405 - $453	7 Added 0.19%	3,740 $217 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $16,309 - $18,109	256 Added 7.36%	3,733 $239 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $46,391 - $52,618	706 Added 25.48%	3,477 $241 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $189,758 - $224,700	2,771 New	2,771 $199 Million

2,468

1.5B

29.6M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $116B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Register Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Register Financial Advisors LLC with notifications on news.